GLP-1 Receptor Agonists Don ' t Raise Thyroid Cancer Risk GLP-1 Receptor Agonists Don ' t Raise Thyroid Cancer Risk
A cohort study in three Scandinavian countries found no significant increase in thyroid cancer risk with glucagon-like peptide 1 receptor agonists.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology Clinical Summary Source Type: news
More News: Cancer | Cancer & Oncology | Diabetes | Endocrinology | PET Scan | Study | Thyroid | Thyroid Cancer